Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Juvenile myoclonic epilepsy]

F J Rogel-Ortíz1

  • 1Departamento de Medicina Interna, Centro Médico, Adolfo Ruiz Cortines, IMSS, Veracruz.

Gaceta Medica De Mexico
|November 1, 1996
PubMed
Summary

Juvenile Myoclonic Epilepsy (JME) affects 4-10% of epilepsy patients, presenting in adolescence with generalized seizures and normal development. Early diagnosis and treatment are crucial but often delayed, highlighting the need for increased physician awareness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Epilepsy in the adult. A prospective study of 100 cases].

Gaceta medica de Mexico·1999
See all related articles

Area of Science:

  • Neurology
  • Epileptology

Background:

  • Juvenile Myoclonic Epilepsy (JME) is a distinct epilepsy syndrome.
  • It affects 4-10% of individuals with epilepsy, typically emerging during adolescence.
  • JME is characterized by generalized seizures (tonic-clonic, absence, myoclonic) in patients with normal neuropsychological development.

Purpose of the Study:

  • To highlight the clinical and electroencephalographic features of JME.
  • To evaluate treatment response in JME patients.
  • To compare findings with existing literature and improve diagnosis/treatment awareness.

Main Methods:

  • Retrospective study of 20 Juvenile Myoclonic Epilepsy patients.
  • Analysis of clinical and electroencephalographic (EEG) profiles.
  • Comparison with published JME case series.

Main Results:

  • Detailed clinical and EEG characteristics of the 20 JME patients were documented.
  • Treatment response patterns were assessed.
  • The study identified key diagnostic and therapeutic aspects of JME.

Conclusions:

  • Juvenile Myoclonic Epilepsy requires greater recognition among physicians, including neurologists and neurosurgeons.
  • Accurate diagnosis and timely treatment are essential for managing JME effectively.
  • This study provides valuable insights for improving patient outcomes in JME.

Related Experiment Videos